Published in Chest on May 01, 2000
Improving end-of-life care for patients with chronic heart failure: "Let's hope it'll get better, when I know in my heart of hearts it won't". Heart (2007) 1.69
End-of-life care conversations with heart failure patients: a systematic literature review and narrative synthesis. Br J Gen Pract (2011) 1.42
New research initiatives in Canada for end-of-life and palliative care. CMAJ (2003) 1.06
Link between decisions regarding resuscitation and preferences for quality over length of life with heart failure. Eur J Heart Fail (2011) 0.89
Time to move advance care planning beyond advance directives. Chest (2000) 0.80
Older Adults Making End of Life Decisions: An Application of Roy's Adaptation Model. J Aging Res (2013) 0.75
Compliance with do-not-resuscitate orders for hospitalized patients transported to radiology departments. Ann Intern Med (1998) 2.14
Advance directive education during pulmonary rehabilitation. Chest (1996) 1.47
Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol (2004) 1.46
Methodologic standards for diagnostic test research in pulmonary medicine. Chest (1998) 1.41
Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest (2000) 1.22
Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol (1997) 1.09
Attitudes regarding advance directives among patients in pulmonary rehabilitation. Am J Respir Crit Care Med (1996) 1.08
Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med (1995) 1.06
The incidence of the grasp reflex following hemispheric lesion and its relation to frontal damage. Brain (1992) 1.04
Outcomes of advance directive education of pulmonary rehabilitation patients. Am J Respir Crit Care Med (1997) 1.01
Images of asteroid 21 Lutetia: a remnant planetesimal from the early Solar System. Science (2011) 0.99
Attentional shift towards the rightmost stimuli in patients with left visual neglect. Cortex (1989) 0.99
Scanning laser polarimetry measurements after laser-assisted in situ keratomileusis. Am J Ophthalmol (2000) 0.99
Oral glucose tolerance and insulin response after one week's clonidine treatment in hypertensive patients. Acta Diabetol Lat (1981) 0.96
Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data. Chest (2000) 0.94
Management of parapneumonic effusions. An analysis of physician practice patterns. Arch Surg (1995) 0.94
Metabolic effects of prazosin. Clin Pharmacol Ther (1980) 0.93
Overcoming the rayleigh criterion limit with optical vortices. Phys Rev Lett (2006) 0.89
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients. J Clin Endocrinol Metab (1986) 0.89
Influence of stimulus salience and attentional demands on visual search patterns in hemispatial neglect. Brain Cogn (1997) 0.89
Metabolic effects of chronic prazosin treatment. Horm Metab Res (1980) 0.88
Auditory neglect. J Neurol Neurosurg Psychiatry (1989) 0.87
Procedure-specific do-not-resuscitate orders. Effect on communication of treatment limitations. Arch Intern Med (1996) 0.87
Communicating do-not-resuscitate orders with a computer-based system. Arch Intern Med (1998) 0.86
Effect of four dopamine receptor antagonists on gastrin secretion in healthy subjects. Scand J Gastroenterol (1980) 0.86
Treatment with gammaglobulin preparation for intravenous use in children with humoral immunodeficiency: clinical and immunologic follow-up. Ann Allergy (1990) 0.85
Lovastatin-induced cholesterol depletion affects both apical sorting and endocytosis of aquaporin-2 in renal cells. Am J Physiol Renal Physiol (2009) 0.85
Effect of loperamide and naloxone on gastric acid secretion in healthy man. Gut (1981) 0.84
Space exploration with and without the aid of vision in hemisphere-damaged patients. Cortex (1989) 0.83
Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions. Arzneimittelforschung (1972) 0.82
Prolactin release by intravenous cimetidine in man: evidence for a suprapituitary locus on action. Clin Endocrinol (Oxf) (1979) 0.81
Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. Nephrol Dial Transplant (1991) 0.81
Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors. J Clin Endocrinol Metab (1980) 0.81
Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma). Int J Cardiol (1996) 0.81
Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy. Maturitas (1982) 0.81
Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man. Eur J Clin Pharmacol (1984) 0.81
True 3D reconstruction for planning of surgery on malformed skulls. Childs Nerv Syst (2002) 0.80
Conservative management of degenerative disorders of the spine. J Neurosurg Sci (2014) 0.80
Effects of advance care education in cardiovascular rehabilitation programs: a prospective randomized study. J Cardiopulm Rehabil (2001) 0.80
Laser radiation and motility patterns of human sperm. Arch Androl (1989) 0.80
Inhibition of the renin-angiotensin-aldosterone system by L-dopa with and without inhibition of extracerebral dopa decarboxylase in man. Clin Sci (Lond) (1981) 0.79
[Ileo-ceco-colic invagination. Apropos of a case caused by lymphoma of the last ileal loop]. Minerva Chir (1980) 0.79
Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction. Acta Endocrinol (Copenh) (1981) 0.79
Effect of loperamide, a peripheral opiate agonist, on circulating glucose, free fatty acids, insulin, C-peptide and pituitary hormones in healthy man. Eur J Clin Pharmacol (1981) 0.79
Growth hormone secretion in hypertensive patients: evidence for a derangement in central adrenergic function. Clin Sci (Lond) (1980) 0.79
Sub-Rayleigh optical vortex coronagraphy. Opt Express (2012) 0.78
Recurrent pneumothoraces in ventilated patients despite ipsilateral chest tubes. Chest (1995) 0.78
Effect of two antiserotoninergic drugs, methysergide and metergoline, on gastric acid secretion and gastrin release in healthy man. Eur J Clin Pharmacol (1980) 0.78
Prolactin stimulation by intravenous labetalol is mediated inside the central nervous system. Clin Endocrinol (Oxf) (1982) 0.78
99mTc SESTAMIBI scintigraphic evaluation of skeletal muscle disease in patients with systemic sclerosis: diagnostic reliability and comparison with cardiac function and perfusion. Angiology (1998) 0.78
Occurrence of pesticides in the Arno River and in potable water--a survey of the period 1992-1995. Bull Environ Contam Toxicol (1997) 0.78
Application of poly-L-lactide screws in flat foot surgery: histological and radiological aspects of bio-absorption of degradable devices. Histol Histopathol (2012) 0.77
VP16 hypersensitivity and increased faulty recombination in ataxia telangiectasia lymphocytes characterized by the tandem translocation t(14;14)(q11;q32). Carcinogenesis (1996) 0.77
Primary gastric lymphoma: a review of 45 cases. Eur J Cancer Clin Oncol (1986) 0.77
Evaluation of new test (Phadiatop) for the screening of respiratory allergic disorders in children. Ann Allergy (1990) 0.77
Telomeric associations and chromosome instability in ataxia telangiectasia T cells characterized by TCL1 expression. Cancer Genet Cytogenet (2001) 0.76
Serotonergic regulation of cortisol secretion in dogs. Endocrinology (1984) 0.76
Effects of kallikrein on the male reproductive system and its use in the treatment of idiopathic oligozoospermia with impaired motility. Andrologia (1987) 0.75
Clinical pharmacology of prazosin: further discussion. Br J Clin Pharmacol (1981) 0.75
Dopaminergic control of gastric acid and gastrin secretion in man: lack of effects after acute oral administration of ibopamine, an analogue of dopamine. Br J Clin Pharmacol (1983) 0.75
Effect of L-dopa with and without inhibition of extra cerebral dopa decarboxylase on gastric acid secretion and gastrin release in man. Gut (1985) 0.75
Improved oral glucose tolerance following antiserotonin treatment in patients with chemical diabetes. Eur J Clin Pharmacol (1979) 0.75
Type of surgical treatment and recurrence of oral leukoplakia: A retrospective clinical study. Med Oral Patol Oral Cir Bucal (2017) 0.75
Clonidine and growth-hormone secretion. Lancet (1979) 0.75
Relationships among pleasure, anxiety and physiological response patterns during the sexual sequence in normal and dispermic subjects. Percept Mot Skills (1985) 0.75
Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man. Clin Endocrinol (Oxf) (1983) 0.75
A practical device for histological fixative procedures that limits formaldehyde deleterious effects in laboratory environments. J Neurosci Methods (1997) 0.75
Central nervous system and pituitary mechanisms in dopaminergic stimulation of growth hormone release in women. Neuroendocrinology (1981) 0.75
Clonidine-induced hyperglycemia: evidence against a growth hormone-mediated effect. J Pharmacol Exp Ther (1980) 0.75
Disappearance of oxytocin-induced uterine tiredness by treatment with fructose-1,6-diphosphate. Experimental evidence. Int J Vitam Nutr Res (1978) 0.75
Predictive modeling of cardiovascular complications in incident hemodialysis patients. Conf Proc IEEE Eng Med Biol Soc (2012) 0.75
Dopamine and stomach. Lancet (1980) 0.75
Lack of effect of deflazacort, a novel glucocorticoid, on basal and TRH-stimulated prolactin and thyrotropin levels in healthy subjects. Eur J Clin Pharmacol (1985) 0.75
Stimulation of prolactin release by intravenous cimetidine: a dose-response study. J Endocrinol Invest (1979) 0.75
Isotopic chains around oxygen from evolved chiral two- and three-nucleon interactions. Phys Rev Lett (2013) 0.75
Effect of antihypertensive drugs on growth hormone secretion. Br Med J (1977) 0.75
[A heap of trouble. Resistant hypertension and aneurysm of the renal artery]. G Ital Nefrol (2004) 0.75
Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects. Clin Pharmacol Ther (1983) 0.75
Lack of effect of cimetidine on the renin-angiotensin-aldosterone system in man. Eur J Clin Pharmacol (1984) 0.75
Near-infrared spectroscopy of dark asteroids. Icarus (1994) 0.75
Hydroa vacciniforme persistent in a 60-year-old man. Eur J Dermatol (1999) 0.75
Inhibition of luteinizing hormone release by dopamine infusion in healthy women and in various pathophysiological conditions. Acta Endocrinol (Copenh) (1981) 0.75
[Experimental replacement of the hepatocholedocus with an autogenous Sparks prosthesis]. Minerva Chir (1984) 0.75
An up-to-date view on persistent idiopathic facial pain. Minerva Stomatol (2009) 0.75
Effect of sulpiride isomers on gastric acid and gastrin secretion in healthy man. Eur J Clin Pharmacol (1983) 0.75
In vitro activity of aztreonam against Pseudomonas: epidemiological aspects. Chemioterapia (1987) 0.75
The standard of orthopaedic radiography in the general hospital. Radiography (1983) 0.75
Immunological studies in patients with central nervous system tumors. J Neurooncol (1987) 0.75
Atypical odontalgia: an up-to-date view. Minerva Stomatol (2013) 0.75
[Psychometric and electromyographic studies in patients with chronic uremia subjected to periodic hemodialysis]. Minerva Med (1983) 0.75
[On the antihypertensive properties of gamma-aminobutyric acid. Clinical experience in 29 hypertensive patients]. Arch Maragliano Patol Clin (1966) 0.75
[Clinical and electromyographic study of hemodialysis patients]. Riv Neurobiol (1982) 0.75
E-type asteroid (2867) Steins as imaged by OSIRIS on board Rosetta. Science (2010) 0.75
[Evaluation of systolic intervals: methodological problems]. Boll Soc Ital Cardiol (1978) 0.75
Effects of FCE20700, a new PGE2 derivative, on gastric acid secretion and cytoprotective processes in man. Eur J Clin Pharmacol (1987) 0.75
[Effect of calciparine in the mid-term treatment of peripheral arteriopathy of the lower extremities]. Minerva Cardioangiol (1993) 0.75
[Orientation strategy implicit in spatial attention]. Boll Soc Ital Biol Sper (1991) 0.75
Vimentine and cytokeratines expression in LoVo cell clones intrinsically resistant to doxorubicin. Cytotechnology (1993) 0.75
Effect of nifedipine on gastric acid secretion and gastrin release in healthy man. Eur J Clin Pharmacol (1985) 0.75